nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—PGR—migraine	0.564	1	CbGaD
Spironolactone—SLCO1A2—Verapamil—migraine	0.0645	0.216	CbGbCtD
Spironolactone—ABCC2—Verapamil—migraine	0.0535	0.179	CbGbCtD
Spironolactone—CYP2C8—Amitriptyline—migraine	0.0325	0.109	CbGbCtD
Spironolactone—CYP2C8—Valproic Acid—migraine	0.0296	0.0989	CbGbCtD
Spironolactone—ABCB1—Timolol—migraine	0.0285	0.0953	CbGbCtD
Spironolactone—CYP2C8—Verapamil—migraine	0.0258	0.0861	CbGbCtD
Spironolactone—ABCB1—Propranolol—migraine	0.0254	0.0849	CbGbCtD
Spironolactone—ABCB1—Amitriptyline—migraine	0.022	0.0735	CbGbCtD
Spironolactone—ABCB1—Verapamil—migraine	0.0174	0.0583	CbGbCtD
Spironolactone—Breast enlargement—Amitriptyline—migraine	0.00279	0.0264	CcSEcCtD
Spironolactone—Breast cancer—Gabapentin—migraine	0.00219	0.0207	CcSEcCtD
Spironolactone—Rash erythematous—Propranolol—migraine	0.00193	0.0182	CcSEcCtD
Spironolactone—Hypertrichosis—Topiramate—migraine	0.00177	0.0167	CcSEcCtD
Spironolactone—Menstruation irregular—Valproic Acid—migraine	0.00174	0.0164	CcSEcCtD
Spironolactone—Gynaecomastia—Amitriptyline—migraine	0.00162	0.0153	CcSEcCtD
Spironolactone—Drug eruption—Valproic Acid—migraine	0.00156	0.0148	CcSEcCtD
Spironolactone—Breast enlargement—Valproic Acid—migraine	0.00148	0.014	CcSEcCtD
Spironolactone—Dydrogesterone—PGR—migraine	0.00147	0.304	CrCbGaD
Spironolactone—Hyperkalaemia—Propranolol—migraine	0.00145	0.0137	CcSEcCtD
Spironolactone—Vasculitis—Verapamil—migraine	0.00139	0.0131	CcSEcCtD
Spironolactone—Drug eruption—Gabapentin—migraine	0.0013	0.0123	CcSEcCtD
Spironolactone—Ataxia—Amitriptyline—migraine	0.00124	0.0117	CcSEcCtD
Spironolactone—Breast enlargement—Gabapentin—migraine	0.00123	0.0116	CcSEcCtD
Spironolactone—Gynaecomastia—Verapamil—migraine	0.00121	0.0115	CcSEcCtD
Spironolactone—Eosinophilia—Amitriptyline—migraine	0.00113	0.0106	CcSEcCtD
Spironolactone—Rash erythematous—Timolol—migraine	0.00112	0.0106	CcSEcCtD
Spironolactone—Amenorrhoea—Valproic Acid—migraine	0.0011	0.0104	CcSEcCtD
Spironolactone—Lethargy—Propranolol—migraine	0.00109	0.0103	CcSEcCtD
Spironolactone—NR3C2—ACE Inhibitor Pathway—ACE—migraine	0.00108	0.0901	CbGpPWpGaD
Spironolactone—Erectile dysfunction—Amitriptyline—migraine	0.00105	0.0099	CcSEcCtD
Spironolactone—Drowsiness—Amitriptyline—migraine	0.00101	0.00958	CcSEcCtD
Spironolactone—Lethargy—Verapamil—migraine	0.00101	0.0095	CcSEcCtD
Spironolactone—Vasculitis—Valproic Acid—migraine	0.000986	0.00932	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Propranolol—migraine	0.000965	0.00912	CcSEcCtD
Spironolactone—Agranulocytosis—Amitriptyline—migraine	0.000946	0.00894	CcSEcCtD
Spironolactone—CYP11B2—cardiovascular system—migraine	0.000934	0.0666	CbGeAlD
Spironolactone—Breast pain—Gabapentin—migraine	0.000915	0.00864	CcSEcCtD
Spironolactone—Amenorrhoea—Gabapentin—migraine	0.000908	0.00858	CcSEcCtD
Spironolactone—Cramp muscle—Verapamil—migraine	0.000887	0.00839	CcSEcCtD
Spironolactone—Megestrol acetate—PGR—migraine	0.000887	0.183	CrCbGaD
Spironolactone—Cramps of lower extremities—Valproic Acid—migraine	0.000884	0.00836	CcSEcCtD
Spironolactone—CYP11B2—ACE Inhibitor Pathway—ACE—migraine	0.000881	0.0737	CbGpPWpGaD
Spironolactone—Rash erythematous—Topiramate—migraine	0.000877	0.00829	CcSEcCtD
Spironolactone—PGR—blood vessel—migraine	0.000859	0.0612	CbGeAlD
Spironolactone—Erectile dysfunction—Propranolol—migraine	0.000853	0.00806	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Propranolol—migraine	0.000819	0.00774	CcSEcCtD
Spironolactone—Alopecia—Amitriptyline—migraine	0.000804	0.0076	CcSEcCtD
Spironolactone—Erectile dysfunction—Verapamil—migraine	0.000784	0.00741	CcSEcCtD
Spironolactone—Drospirenone—PGR—migraine	0.000774	0.16	CrCbGaD
Spironolactone—Agranulocytosis—Propranolol—migraine	0.00077	0.00728	CcSEcCtD
Spironolactone—Breast pain—Topiramate—migraine	0.000769	0.00727	CcSEcCtD
Spironolactone—Amenorrhoea—Topiramate—migraine	0.000764	0.00722	CcSEcCtD
Spironolactone—Drowsiness—Verapamil—migraine	0.000759	0.00718	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Verapamil—migraine	0.000753	0.00712	CcSEcCtD
Spironolactone—Ill-defined disorder—Amitriptyline—migraine	0.000735	0.00695	CcSEcCtD
Spironolactone—Cramps of lower extremities—Gabapentin—migraine	0.000733	0.00693	CcSEcCtD
Spironolactone—Malaise—Amitriptyline—migraine	0.000715	0.00675	CcSEcCtD
Spironolactone—Gynaecomastia—Gabapentin—migraine	0.000714	0.00675	CcSEcCtD
Spironolactone—Lethargy—Valproic Acid—migraine	0.000713	0.00674	CcSEcCtD
Spironolactone—Leukopenia—Amitriptyline—migraine	0.000709	0.0067	CcSEcCtD
Spironolactone—Erythema multiforme—Propranolol—migraine	0.000701	0.00662	CcSEcCtD
Spironolactone—SHBG—neck—migraine	0.000682	0.0486	CbGeAlD
Spironolactone—Discomfort—Amitriptyline—migraine	0.000667	0.0063	CcSEcCtD
Spironolactone—Ataxia—Valproic Acid—migraine	0.000657	0.00621	CcSEcCtD
Spironolactone—Alopecia—Propranolol—migraine	0.000655	0.00619	CcSEcCtD
Spironolactone—Confusional state—Amitriptyline—migraine	0.000652	0.00616	CcSEcCtD
Spironolactone—Erythema multiforme—Verapamil—migraine	0.000645	0.00609	CcSEcCtD
Spironolactone—Thrombocytopenia—Amitriptyline—migraine	0.000633	0.00598	CcSEcCtD
Spironolactone—NR3C1—nerve—migraine	0.000631	0.045	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Valproic Acid—migraine	0.000629	0.00595	CcSEcCtD
Spironolactone—Renal failure acute—Gabapentin—migraine	0.000627	0.00593	CcSEcCtD
Spironolactone—Cramps of lower extremities—Topiramate—migraine	0.000617	0.00583	CcSEcCtD
Spironolactone—Alopecia—Verapamil—migraine	0.000602	0.00569	CcSEcCtD
Spironolactone—Eosinophilia—Valproic Acid—migraine	0.000598	0.00565	CcSEcCtD
Spironolactone—Lethargy—Gabapentin—migraine	0.000591	0.00559	CcSEcCtD
Spironolactone—Somnolence—Amitriptyline—migraine	0.000575	0.00543	CcSEcCtD
Spironolactone—Muscle spasms—Verapamil—migraine	0.000571	0.00539	CcSEcCtD
Spironolactone—NR3C2—trigeminal ganglion—migraine	0.000571	0.0407	CbGeAlD
Spironolactone—Ataxia—Gabapentin—migraine	0.000545	0.00515	CcSEcCtD
Spironolactone—Drowsiness—Valproic Acid—migraine	0.000538	0.00509	CcSEcCtD
Spironolactone—SHBG—Nongenotropic Androgen signaling—FOS—migraine	0.000534	0.0446	CbGpPWpGaD
Spironolactone—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000534	0.00505	CcSEcCtD
Spironolactone—Feeling abnormal—Amitriptyline—migraine	0.000533	0.00504	CcSEcCtD
Spironolactone—Anaphylactic shock—Propranolol—migraine	0.000527	0.00498	CcSEcCtD
Spironolactone—SHBG—brainstem—migraine	0.000521	0.0371	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—PGR—migraine	0.000517	0.107	CrCbGaD
Spironolactone—Urticaria—Amitriptyline—migraine	0.000514	0.00486	CcSEcCtD
Spironolactone—Gastritis—Gabapentin—migraine	0.000513	0.00484	CcSEcCtD
Spironolactone—Body temperature increased—Amitriptyline—migraine	0.000511	0.00483	CcSEcCtD
Spironolactone—NR3C2—brainstem—migraine	0.000505	0.036	CbGeAlD
Spironolactone—Agranulocytosis—Valproic Acid—migraine	0.000503	0.00475	CcSEcCtD
Spironolactone—Discomfort—Verapamil—migraine	0.000499	0.00472	CcSEcCtD
Spironolactone—Lethargy—Topiramate—migraine	0.000497	0.0047	CcSEcCtD
Spironolactone—NR3C2—Nuclear Receptor transcription pathway—PGR—migraine	0.000497	0.0416	CbGpPWpGaD
Spironolactone—Eosinophilia—Gabapentin—migraine	0.000496	0.00468	CcSEcCtD
Spironolactone—Erectile dysfunction—Timolol—migraine	0.000495	0.00468	CcSEcCtD
Spironolactone—Confusional state—Verapamil—migraine	0.000488	0.00462	CcSEcCtD
Spironolactone—Anaphylactic shock—Verapamil—migraine	0.000484	0.00458	CcSEcCtD
Spironolactone—Somnolence—Propranolol—migraine	0.000468	0.00442	CcSEcCtD
Spironolactone—Erectile dysfunction—Gabapentin—migraine	0.000461	0.00436	CcSEcCtD
Spironolactone—Ataxia—Topiramate—migraine	0.000458	0.00433	CcSEcCtD
Spironolactone—Pruritus—Amitriptyline—migraine	0.000458	0.00432	CcSEcCtD
Spironolactone—Erythema multiforme—Valproic Acid—migraine	0.000457	0.00432	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Propranolol—migraine	0.000455	0.0043	CcSEcCtD
Spironolactone—Agranulocytosis—Timolol—migraine	0.000447	0.00423	CcSEcCtD
Spironolactone—Drowsiness—Gabapentin—migraine	0.000446	0.00422	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Gabapentin—migraine	0.000443	0.00418	CcSEcCtD
Spironolactone—Diarrhoea—Amitriptyline—migraine	0.000442	0.00418	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Topiramate—migraine	0.000439	0.00415	CcSEcCtD
Spironolactone—Renal failure—Gabapentin—migraine	0.000439	0.00415	CcSEcCtD
Spironolactone—Gastritis—Topiramate—migraine	0.000431	0.00408	CcSEcCtD
Spironolactone—Somnolence—Verapamil—migraine	0.000431	0.00407	CcSEcCtD
Spironolactone—Dizziness—Amitriptyline—migraine	0.000428	0.00404	CcSEcCtD
Spironolactone—Alopecia—Valproic Acid—migraine	0.000427	0.00404	CcSEcCtD
Spironolactone—SHBG—cardiovascular system—migraine	0.000425	0.0303	CbGeAlD
Spironolactone—Urticaria—Propranolol—migraine	0.000418	0.00395	CcSEcCtD
Spironolactone—Eosinophilia—Topiramate—migraine	0.000417	0.00394	CcSEcCtD
Spironolactone—Body temperature increased—Propranolol—migraine	0.000416	0.00393	CcSEcCtD
Spironolactone—NR3C2—cardiovascular system—migraine	0.000412	0.0294	CbGeAlD
Spironolactone—Vomiting—Amitriptyline—migraine	0.000411	0.00389	CcSEcCtD
Spironolactone—Rash—Amitriptyline—migraine	0.000408	0.00385	CcSEcCtD
Spironolactone—Dermatitis—Amitriptyline—migraine	0.000407	0.00385	CcSEcCtD
Spironolactone—Headache—Amitriptyline—migraine	0.000405	0.00383	CcSEcCtD
Spironolactone—Muscle spasms—Valproic Acid—migraine	0.000405	0.00382	CcSEcCtD
Spironolactone—Feeling abnormal—Verapamil—migraine	0.000399	0.00377	CcSEcCtD
Spironolactone—Ill-defined disorder—Valproic Acid—migraine	0.00039	0.00369	CcSEcCtD
Spironolactone—Hypersensitivity—Propranolol—migraine	0.000388	0.00367	CcSEcCtD
Spironolactone—Erectile dysfunction—Topiramate—migraine	0.000388	0.00367	CcSEcCtD
Spironolactone—Urticaria—Verapamil—migraine	0.000385	0.00364	CcSEcCtD
Spironolactone—Nausea—Amitriptyline—migraine	0.000384	0.00363	CcSEcCtD
Spironolactone—PGR—cardiovascular system—migraine	0.000383	0.0273	CbGeAlD
Spironolactone—Alopecia—Timolol—migraine	0.00038	0.00359	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—migraine	0.00038	0.0785	CrCbGaD
Spironolactone—Malaise—Valproic Acid—migraine	0.000379	0.00359	CcSEcCtD
Spironolactone—Erythema multiforme—Gabapentin—migraine	0.000379	0.00358	CcSEcCtD
Spironolactone—Leukopenia—Valproic Acid—migraine	0.000377	0.00356	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Topiramate—migraine	0.000372	0.00352	CcSEcCtD
Spironolactone—Renal failure—Topiramate—migraine	0.000369	0.00349	CcSEcCtD
Spironolactone—Diarrhoea—Propranolol—migraine	0.00036	0.0034	CcSEcCtD
Spironolactone—Hypersensitivity—Verapamil—migraine	0.000357	0.00337	CcSEcCtD
Spironolactone—NR3C1—neck—migraine	0.000354	0.0253	CbGeAlD
Spironolactone—Alopecia—Gabapentin—migraine	0.000354	0.00335	CcSEcCtD
Spironolactone—Discomfort—Valproic Acid—migraine	0.000354	0.00335	CcSEcCtD
Spironolactone—Agranulocytosis—Topiramate—migraine	0.00035	0.00331	CcSEcCtD
Spironolactone—Dizziness—Propranolol—migraine	0.000348	0.00329	CcSEcCtD
Spironolactone—Confusional state—Valproic Acid—migraine	0.000346	0.00327	CcSEcCtD
Spironolactone—Anaphylactic shock—Valproic Acid—migraine	0.000343	0.00325	CcSEcCtD
Spironolactone—Pruritus—Verapamil—migraine	0.000343	0.00324	CcSEcCtD
Spironolactone—Thrombocytopenia—Valproic Acid—migraine	0.000336	0.00318	CcSEcCtD
Spironolactone—Muscle spasms—Gabapentin—migraine	0.000335	0.00317	CcSEcCtD
Spironolactone—Vomiting—Propranolol—migraine	0.000335	0.00316	CcSEcCtD
Spironolactone—Rash—Propranolol—migraine	0.000332	0.00314	CcSEcCtD
Spironolactone—Dermatitis—Propranolol—migraine	0.000332	0.00313	CcSEcCtD
Spironolactone—Diarrhoea—Verapamil—migraine	0.000331	0.00313	CcSEcCtD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.000331	0.0277	CbGpPWpGaD
Spironolactone—Medroxyprogesterone Acetate—ESR1—migraine	0.000326	0.0673	CrCbGaD
Spironolactone—Ill-defined disorder—Gabapentin—migraine	0.000324	0.00306	CcSEcCtD
Spironolactone—NR3C1—Circadian Clock—MEF2D—migraine	0.000322	0.0269	CbGpPWpGaD
Spironolactone—Dizziness—Verapamil—migraine	0.00032	0.00303	CcSEcCtD
Spironolactone—Erythema multiforme—Topiramate—migraine	0.000319	0.00301	CcSEcCtD
Spironolactone—Discomfort—Timolol—migraine	0.000315	0.00298	CcSEcCtD
Spironolactone—Malaise—Gabapentin—migraine	0.000315	0.00297	CcSEcCtD
Spironolactone—Nausea—Propranolol—migraine	0.000313	0.00296	CcSEcCtD
Spironolactone—Leukopenia—Gabapentin—migraine	0.000312	0.00295	CcSEcCtD
Spironolactone—Confusional state—Timolol—migraine	0.000308	0.00291	CcSEcCtD
Spironolactone—Vomiting—Verapamil—migraine	0.000308	0.00291	CcSEcCtD
Spironolactone—NR3C1—trigeminal ganglion—migraine	0.000306	0.0218	CbGeAlD
Spironolactone—Anaphylactic shock—Timolol—migraine	0.000306	0.00289	CcSEcCtD
Spironolactone—Rash—Verapamil—migraine	0.000305	0.00289	CcSEcCtD
Spironolactone—Somnolence—Valproic Acid—migraine	0.000305	0.00289	CcSEcCtD
Spironolactone—AR—cardiovascular system—migraine	0.000305	0.0218	CbGeAlD
Spironolactone—Dermatitis—Verapamil—migraine	0.000305	0.00288	CcSEcCtD
Spironolactone—Headache—Verapamil—migraine	0.000303	0.00287	CcSEcCtD
Spironolactone—Progesterone—PGR—migraine	0.000298	0.0616	CrCbGaD
Spironolactone—Alopecia—Topiramate—migraine	0.000298	0.00282	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Valproic Acid—migraine	0.000297	0.0028	CcSEcCtD
Spironolactone—Discomfort—Gabapentin—migraine	0.000293	0.00277	CcSEcCtD
Spironolactone—AR—Nuclear Receptors—PGR—migraine	0.000292	0.0244	CbGpPWpGaD
Spironolactone—Nausea—Verapamil—migraine	0.000288	0.00272	CcSEcCtD
Spironolactone—Confusional state—Gabapentin—migraine	0.000287	0.00271	CcSEcCtD
Spironolactone—Anaphylactic shock—Gabapentin—migraine	0.000285	0.00269	CcSEcCtD
Spironolactone—Feeling abnormal—Valproic Acid—migraine	0.000283	0.00267	CcSEcCtD
Spironolactone—Muscle spasms—Topiramate—migraine	0.000282	0.00267	CcSEcCtD
Spironolactone—NR3C2—head—migraine	0.000279	0.0199	CbGeAlD
Spironolactone—Thrombocytopenia—Gabapentin—migraine	0.000279	0.00263	CcSEcCtD
Spironolactone—Urticaria—Valproic Acid—migraine	0.000273	0.00258	CcSEcCtD
Spironolactone—Ill-defined disorder—Topiramate—migraine	0.000272	0.00257	CcSEcCtD
Spironolactone—Somnolence—Timolol—migraine	0.000272	0.00257	CcSEcCtD
Spironolactone—Body temperature increased—Valproic Acid—migraine	0.000271	0.00257	CcSEcCtD
Spironolactone—NR3C1—brainstem—migraine	0.000271	0.0193	CbGeAlD
Spironolactone—NR3C2—Nuclear Receptor transcription pathway—ESR1—migraine	0.000265	0.0222	CbGpPWpGaD
Spironolactone—ABCB1—blood vessel—migraine	0.000265	0.0189	CbGeAlD
Spironolactone—Malaise—Topiramate—migraine	0.000265	0.0025	CcSEcCtD
Spironolactone—NR3C2—nervous system—migraine	0.000265	0.0189	CbGeAlD
Spironolactone—Gastrointestinal disorder—Timolol—migraine	0.000264	0.00249	CcSEcCtD
Spironolactone—SHBG—central nervous system—migraine	0.000263	0.0187	CbGeAlD
Spironolactone—Leukopenia—Topiramate—migraine	0.000263	0.00248	CcSEcCtD
Spironolactone—PGR—head—migraine	0.000259	0.0185	CbGeAlD
Spironolactone—SHBG—cerebellum—migraine	0.000257	0.0183	CbGeAlD
Spironolactone—NR3C2—central nervous system—migraine	0.000255	0.0182	CbGeAlD
Spironolactone—Somnolence—Gabapentin—migraine	0.000253	0.00239	CcSEcCtD
Spironolactone—Hypersensitivity—Valproic Acid—migraine	0.000253	0.00239	CcSEcCtD
Spironolactone—Feeling abnormal—Timolol—migraine	0.000252	0.00238	CcSEcCtD
Spironolactone—NR3C2—cerebellum—migraine	0.000249	0.0177	CbGeAlD
Spironolactone—Discomfort—Topiramate—migraine	0.000247	0.00233	CcSEcCtD
Spironolactone—PGR—nervous system—migraine	0.000246	0.0175	CbGeAlD
Spironolactone—Gastrointestinal disorder—Gabapentin—migraine	0.000246	0.00232	CcSEcCtD
Spironolactone—Pruritus—Valproic Acid—migraine	0.000243	0.0023	CcSEcCtD
Spironolactone—Urticaria—Timolol—migraine	0.000243	0.0023	CcSEcCtD
Spironolactone—Body temperature increased—Timolol—migraine	0.000242	0.00228	CcSEcCtD
Spironolactone—Confusional state—Topiramate—migraine	0.000242	0.00228	CcSEcCtD
Spironolactone—SLCO1A2—head—migraine	0.000239	0.0171	CbGeAlD
Spironolactone—AR—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000237	0.0198	CbGpPWpGaD
Spironolactone—PGR—central nervous system—migraine	0.000237	0.0169	CbGeAlD
Spironolactone—Diarrhoea—Valproic Acid—migraine	0.000235	0.00222	CcSEcCtD
Spironolactone—Feeling abnormal—Gabapentin—migraine	0.000235	0.00222	CcSEcCtD
Spironolactone—Thrombocytopenia—Topiramate—migraine	0.000235	0.00222	CcSEcCtD
Spironolactone—PGR—cerebellum—migraine	0.000231	0.0165	CbGeAlD
Spironolactone—AR—Nuclear Receptor transcription pathway—PGR—migraine	0.000231	0.0193	CbGpPWpGaD
Spironolactone—Dizziness—Valproic Acid—migraine	0.000227	0.00215	CcSEcCtD
Spironolactone—SLCO1A2—nervous system—migraine	0.000227	0.0162	CbGeAlD
Spironolactone—Urticaria—Gabapentin—migraine	0.000226	0.00214	CcSEcCtD
Spironolactone—Hypersensitivity—Timolol—migraine	0.000225	0.00213	CcSEcCtD
Spironolactone—Body temperature increased—Gabapentin—migraine	0.000225	0.00213	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptors—PGR—migraine	0.000221	0.0185	CbGpPWpGaD
Spironolactone—NR3C1—cardiovascular system—migraine	0.000221	0.0158	CbGeAlD
Spironolactone—Vomiting—Valproic Acid—migraine	0.000218	0.00206	CcSEcCtD
Spironolactone—SLCO1A2—central nervous system—migraine	0.000218	0.0156	CbGeAlD
Spironolactone—Rash—Valproic Acid—migraine	0.000217	0.00205	CcSEcCtD
Spironolactone—Dermatitis—Valproic Acid—migraine	0.000216	0.00204	CcSEcCtD
Spironolactone—Pruritus—Timolol—migraine	0.000216	0.00204	CcSEcCtD
Spironolactone—Headache—Valproic Acid—migraine	0.000215	0.00203	CcSEcCtD
Spironolactone—SLCO1A2—cerebellum—migraine	0.000213	0.0152	CbGeAlD
Spironolactone—Somnolence—Topiramate—migraine	0.000213	0.00201	CcSEcCtD
Spironolactone—Hypersensitivity—Gabapentin—migraine	0.00021	0.00198	CcSEcCtD
Spironolactone—Diarrhoea—Timolol—migraine	0.000209	0.00198	CcSEcCtD
Spironolactone—SHBG—brain—migraine	0.000209	0.0149	CbGeAlD
Spironolactone—Gastrointestinal disorder—Topiramate—migraine	0.000207	0.00195	CcSEcCtD
Spironolactone—AR—head—migraine	0.000207	0.0147	CbGeAlD
Spironolactone—PGR—Nuclear Receptors—ESR1—migraine	0.000205	0.0171	CbGpPWpGaD
Spironolactone—Nausea—Valproic Acid—migraine	0.000204	0.00193	CcSEcCtD
Spironolactone—NR3C2—brain—migraine	0.000202	0.0144	CbGeAlD
Spironolactone—Dizziness—Timolol—migraine	0.000202	0.00191	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—HTR3A—migraine	0.000201	0.0168	CbGpPWpGaD
Spironolactone—Pruritus—Gabapentin—migraine	0.000201	0.0019	CcSEcCtD
Spironolactone—PGR—Nuclear signaling by ERBB4—ESR1—migraine	0.0002	0.0167	CbGpPWpGaD
Spironolactone—Feeling abnormal—Topiramate—migraine	0.000197	0.00187	CcSEcCtD
Spironolactone—AR—nervous system—migraine	0.000196	0.014	CbGeAlD
Spironolactone—Diarrhoea—Gabapentin—migraine	0.000195	0.00184	CcSEcCtD
Spironolactone—Vomiting—Timolol—migraine	0.000194	0.00184	CcSEcCtD
Spironolactone—Rash—Timolol—migraine	0.000193	0.00182	CcSEcCtD
Spironolactone—Dermatitis—Timolol—migraine	0.000193	0.00182	CcSEcCtD
Spironolactone—Headache—Timolol—migraine	0.000192	0.00181	CcSEcCtD
Spironolactone—Urticaria—Topiramate—migraine	0.00019	0.0018	CcSEcCtD
Spironolactone—Body temperature increased—Topiramate—migraine	0.000189	0.00179	CcSEcCtD
Spironolactone—AR—central nervous system—migraine	0.000189	0.0134	CbGeAlD
Spironolactone—Progesterone—ESR1—migraine	0.000188	0.0389	CrCbGaD
Spironolactone—Dizziness—Gabapentin—migraine	0.000188	0.00178	CcSEcCtD
Spironolactone—PGR—brain—migraine	0.000188	0.0134	CbGeAlD
Spironolactone—Nausea—Timolol—migraine	0.000182	0.00172	CcSEcCtD
Spironolactone—Vomiting—Gabapentin—migraine	0.000181	0.00171	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00018	0.015	CbGpPWpGaD
Spironolactone—Rash—Gabapentin—migraine	0.00018	0.0017	CcSEcCtD
Spironolactone—Dermatitis—Gabapentin—migraine	0.000179	0.00169	CcSEcCtD
Spironolactone—Headache—Gabapentin—migraine	0.000178	0.00169	CcSEcCtD
Spironolactone—Hypersensitivity—Topiramate—migraine	0.000176	0.00167	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—PGR—migraine	0.000175	0.0146	CbGpPWpGaD
Spironolactone—SLCO1A2—brain—migraine	0.000173	0.0124	CbGeAlD
Spironolactone—Pruritus—Topiramate—migraine	0.000169	0.0016	CcSEcCtD
Spironolactone—Nausea—Gabapentin—migraine	0.000169	0.0016	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—FOS—migraine	0.000165	0.0138	CbGpPWpGaD
Spironolactone—Diarrhoea—Topiramate—migraine	0.000164	0.00155	CcSEcCtD
Spironolactone—ABCB1—trigeminal ganglion—migraine	0.000164	0.0117	CbGeAlD
Spironolactone—NR3C1—Adipogenesis—MEF2D—migraine	0.000162	0.0135	CbGpPWpGaD
Spironolactone—PGR—Nuclear Receptor transcription pathway—ESR1—migraine	0.000162	0.0135	CbGpPWpGaD
Spironolactone—Dizziness—Topiramate—migraine	0.000158	0.0015	CcSEcCtD
Spironolactone—AR—Nuclear Receptors—ESR1—migraine	0.000156	0.013	CbGpPWpGaD
Spironolactone—PGR—Cellular roles of Anthrax toxin—TNF—migraine	0.000154	0.0128	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HTR3A—migraine	0.000153	0.0128	CbGpPWpGaD
Spironolactone—Vomiting—Topiramate—migraine	0.000152	0.00144	CcSEcCtD
Spironolactone—Rash—Topiramate—migraine	0.000151	0.00143	CcSEcCtD
Spironolactone—Dermatitis—Topiramate—migraine	0.000151	0.00143	CcSEcCtD
Spironolactone—Headache—Topiramate—migraine	0.00015	0.00142	CcSEcCtD
Spironolactone—AR—brain—migraine	0.00015	0.0107	CbGeAlD
Spironolactone—NR3C1—head—migraine	0.00015	0.0107	CbGeAlD
Spironolactone—Nausea—Topiramate—migraine	0.000142	0.00134	CcSEcCtD
Spironolactone—NR3C1—nervous system—migraine	0.000142	0.0101	CbGeAlD
Spironolactone—AR—FOXA1 transcription factor network—ESR1—migraine	0.000139	0.0116	CbGpPWpGaD
Spironolactone—NR3C1—central nervous system—migraine	0.000137	0.00974	CbGeAlD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—ESR1—migraine	0.000135	0.0113	CbGpPWpGaD
Spironolactone—NR3C1—cerebellum—migraine	0.000134	0.00952	CbGeAlD
Spironolactone—AR—FOXA1 transcription factor network—FOS—migraine	0.000125	0.0104	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptor transcription pathway—ESR1—migraine	0.000123	0.0103	CbGpPWpGaD
Spironolactone—CYP2C8—brain—migraine	0.000121	0.00863	CbGeAlD
Spironolactone—ABCB1—cardiovascular system—migraine	0.000118	0.00844	CbGeAlD
Spironolactone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—migraine	0.000118	0.00988	CbGpPWpGaD
Spironolactone—NR3C1—Nuclear Receptors—ESR1—migraine	0.000118	0.00988	CbGpPWpGaD
Spironolactone—NR3C1—brain—migraine	0.000108	0.00773	CbGeAlD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—FOS—migraine	0.000105	0.00879	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000101	0.0084	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—HTR1A—migraine	9.58e-05	0.00801	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TAC1—migraine	9.43e-05	0.00788	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—NOTCH4—migraine	9.39e-05	0.00785	CbGpPWpGaD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—ESR1—migraine	9.35e-05	0.00781	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—SLC6A4—migraine	9.25e-05	0.00773	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TRPM8—migraine	9.15e-05	0.00765	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—TNF—migraine	8.87e-05	0.00742	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—PGR—migraine	8.59e-05	0.00718	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	8.51e-05	0.00711	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—SLC6A4—migraine	8.46e-05	0.00707	CbGpPWpGaD
Spironolactone—ABCB1—head—migraine	8.01e-05	0.00571	CbGeAlD
Spironolactone—NR3C2—Generic Transcription Pathway—NOTCH3—migraine	7.98e-05	0.00667	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	7.67e-05	0.00641	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ATP1A2—migraine	7.62e-05	0.00637	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ATP1A3—migraine	7.62e-05	0.00637	CbGpPWpGaD
Spironolactone—ABCB1—nervous system—migraine	7.6e-05	0.00542	CbGeAlD
Spironolactone—ABCB1—central nervous system—migraine	7.31e-05	0.00521	CbGeAlD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HTR1A—migraine	7.27e-05	0.00607	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—ESR1—migraine	7.25e-05	0.00606	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TGFBR2—migraine	7.16e-05	0.00599	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TAC1—migraine	7.16e-05	0.00598	CbGpPWpGaD
Spironolactone—ABCB1—cerebellum—migraine	7.15e-05	0.0051	CbGeAlD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—migraine	7.02e-05	0.00587	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ATP1A3—migraine	6.94e-05	0.0058	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ATP1A2—migraine	6.94e-05	0.0058	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—ESR1—migraine	6.75e-05	0.00564	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—BDNF—migraine	6.72e-05	0.00561	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—FOS—migraine	6.54e-05	0.00546	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—HTR3A—migraine	6.48e-05	0.00541	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	6.46e-05	0.0054	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFBR2—migraine	6.38e-05	0.00533	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—HTR3A—migraine	5.9e-05	0.00493	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	5.82e-05	0.00486	CbGpPWpGaD
Spironolactone—ABCB1—brain—migraine	5.81e-05	0.00414	CbGeAlD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—FOS—migraine	5.76e-05	0.00481	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—NOTCH4—migraine	5.72e-05	0.00478	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	5.71e-05	0.00477	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—HTR2A—migraine	5.67e-05	0.00474	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—ESR1—migraine	5.17e-05	0.00432	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—BDNF—migraine	5.1e-05	0.00426	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—NOTCH3—migraine	4.86e-05	0.00406	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CACNA1A—migraine	4.77e-05	0.00399	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—ESR1—migraine	4.59e-05	0.00383	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NOTCH4—migraine	4.52e-05	0.00378	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NOTCH4—migraine	4.36e-05	0.00364	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HTR2A—migraine	4.31e-05	0.0036	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	4.3e-05	0.0036	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	4.28e-05	0.00358	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PGR—migraine	4.13e-05	0.00346	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CACNA1A—migraine	4.11e-05	0.00344	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PGR—migraine	3.99e-05	0.00333	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAMP1—migraine	3.92e-05	0.00328	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CALCRL—migraine	3.92e-05	0.00328	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NOTCH3—migraine	3.84e-05	0.00321	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NOTCH3—migraine	3.7e-05	0.0031	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	3.68e-05	0.00308	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH4—migraine	3.31e-05	0.00276	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	3.26e-05	0.00273	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	3.26e-05	0.00273	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PGR—migraine	3.02e-05	0.00253	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR1D—migraine	2.85e-05	0.00238	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH3—migraine	2.81e-05	0.00235	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—ESR1—migraine	2.79e-05	0.00233	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	2.77e-05	0.00232	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH4—migraine	2.75e-05	0.0023	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR2B—migraine	2.65e-05	0.00222	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CACNA1A—migraine	2.58e-05	0.00216	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—migraine	2.44e-05	0.00204	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH3—migraine	2.34e-05	0.00196	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LRP1—migraine	2.33e-05	0.00195	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.33e-05	0.00195	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR1—migraine	2.21e-05	0.00185	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—migraine	2.14e-05	0.00179	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR1—migraine	2.13e-05	0.00178	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH4—migraine	2.1e-05	0.00175	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.08e-05	0.00173	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PGR—migraine	1.92e-05	0.0016	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—migraine	1.85e-05	0.00155	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH4—migraine	1.79e-05	0.0015	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH3—migraine	1.78e-05	0.00149	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.75e-05	0.00146	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR1B—migraine	1.73e-05	0.00144	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—migraine	1.71e-05	0.00143	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR1A—migraine	1.66e-05	0.00139	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NPS—migraine	1.64e-05	0.00137	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TAC1—migraine	1.64e-05	0.00137	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR1—migraine	1.61e-05	0.00135	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR2C—migraine	1.61e-05	0.00134	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH4—migraine	1.59e-05	0.00133	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MTHFR—migraine	1.58e-05	0.00132	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EDNRA—migraine	1.56e-05	0.00131	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH3—migraine	1.52e-05	0.00127	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CALCA—migraine	1.5e-05	0.00126	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PGR—migraine	1.46e-05	0.00122	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR7—migraine	1.41e-05	0.00118	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—migraine	1.36e-05	0.00114	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH3—migraine	1.35e-05	0.00113	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR1—migraine	1.34e-05	0.00112	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CACNA1A—migraine	1.27e-05	0.00106	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFBR2—migraine	1.21e-05	0.00101	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CACNA1A—migraine	1.1e-05	0.000923	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—migraine	1.02e-05	0.000856	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR2A—migraine	9.85e-06	0.000823	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—migraine	8.74e-06	0.000731	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—migraine	8.53e-06	0.000713	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	8.46e-06	0.000707	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—migraine	7.77e-06	0.00065	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—migraine	4.19e-06	0.00035	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—migraine	3.65e-06	0.000305	CbGpPWpGaD
